Manulife (Manufacturers Life Insurance)’s Akcea Therapeutics Inc AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11,870
Closed -$215K 3084
2020
Q3
$215K Hold
11,870
﹤0.01% 2518
2020
Q2
$170K Buy
11,870
+1,468
+14% +$22.7K ﹤0.01% 2572
2020
Q1
$149K Buy
+10,402
New +$171K ﹤0.01% 2450
2019
Q4
Sell
-10,179
Closed -$165K 2928
2019
Q3
$165K Buy
10,179
+67
+0.7% +$1.43K ﹤0.01% 2675
2019
Q2
$237K Buy
+10,112
New +$250K ﹤0.01% 2525
2018
Q4
Sell
-6,291
Closed -$220K 2899
2018
Q3
$220K Sell
6,291
-5,396
-46% -$163K ﹤0.01% 2712
2018
Q2
$277K Sell
11,687
-1,328
-10% -$31.7K ﹤0.01% 2848
2018
Q1
$333K Sell
13,015
-223
-2% -$4.8K ﹤0.01% 2637
2017
Q4
$230K Buy
13,238
+2,123
+19% +$41.6K ﹤0.01% 2896
2017
Q3
$308K Buy
+11,115
New +$206K ﹤0.01% 2629

Manulife (Manufacturers Life Insurance)'s AKCA Position: Q4 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 11,870 shares — an estimated $215K sold.

Manulife (Manufacturers Life Insurance) first reported a position in AKCA in Q3 2017 and held it in 10 quarters. The position peaked at $333K in Q1 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 11,870 Akcea Therapeutics Inc shares in Q4 2020, an estimated $215K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 10 quarters.
  • Manulife (Manufacturers Life Insurance)'s Akcea Therapeutics Inc position peaked at $333K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2020, filed 12 Feb 2021.